Full Text View
Tabular View
No Study Results Posted
Related Studies
An Evaluation of Aranesp® in Subjects With Anaemic Chronic Kidney Disease (CKD)
This study has been completed.
Study NCT00124098   Information provided by Amgen
First Received: June 30, 2005   Last Updated: June 13, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Kidney Disease
Additional conditions recognized in this trial
Kidney Diseases
Kidney Failure, Chronic
Renal Insufficiency, Chronic
More general conditions related to this trial
Kidney Failure
Renal Insufficiency
Urologic Diseases
Interventions listed in this trial
Aranesp® (darbepoetin alfa)
Additional drug interventions recognized in this trial
Darbepoetin alfa
More general drug interventions related to this trial
Hematinics
Hematologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Amgen


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services